No specific mRNA target

No specific mRNA target is a designation used for therapeutic agents, primarily mRNA vaccines, that do not interact with or modulate a specific endogenous host mRNA sequence. Instead of acting as an inhibitor or modulator of a target protein or nucleotide, these agents provide an exogenous mRNA template that the host's cellular machinery translates into a functional protein, such as a viral antigen (Sahin et al., 2014, Nature Reviews Drug Discovery). This approach is central to the technology used in COVID-19 vaccines, where the mRNA encodes the SARS-CoV-2 spike protein to elicit an immune response (Pardi et al., 2018, Nature Reviews Drug Discovery). Because the mechanism involves the introduction of genetic information rather than the binding to a specific biological target, it is classified as having no specific mRNA target within the host genome. This term is often used as a placeholder in clinical databases for therapies where the target is the immune system or the protein production process itself. Consequently, it does not fit the standard definition of a therapeutic target in the context of drug-receptor interactions. This classification highlights the distinction between traditional small molecule or antibody drugs and platform-based genetic medicines.

Translation of exogenous mRNA into protein